Detection of HTLV-I in clinical specimens.
The American Red Cross, which collects 50% of blood for transfusion in the United States, now tests all prospective blood donors for HTLV-I and HTLV-II antibodies. It will therefore be important to recognize the significance and clinical spectrum of diseases associated with these viruses, and to become familiar with the current methods used to diagnose infection. This review summarizes the techniques currently in use to screen for HTLV-I/II antibodies, as well as methods to detect viral genome and/or gene products in blood and tissue specimens.
D015485:Deltaretrovirus Antigens / Q000032:analysis; D015481:HTLV-I Antibodies / Q000097:blood*; D015490:HTLV-I Infections / Q000175:diagnosis*; D015368:Human T-lymphotropic virus 1 / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification*; D006801:Humans; D007159:Immunologic Tests; D017403:In Situ Hybridization; D016133:Polymerase Chain Reaction; D012194:RNA-Directed DNA Polymerase / Q000032:analysis
D015485:Deltaretrovirus Antigens; D015481:HTLV-I Antibodies; D012194:RNA-Directed DNA Polymerase